noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

News > Healthcare

related tags Healthcare Service Providers Biotechnology Biotech Industry Medical Technology and Devices HIV/AIDS Health Organizations Health-Workers Union More

Results Healthcare

Merck & Co. Inc.

SOLO-1 Phase 3 Trial Demonstrates LYNPARZA® (olaparib) Maintenance Therapy Cut the Risk of Disease Progression or Death by 70 Percent in Patients with Newly-Diagnosed, Advanced BRCA-Mutated Ovarian Cancer

-4h 32m
Varian Medical Systems Inc.

Varian Outlines Strategy for AI-Driven Multimodality Adaptive Radiotherapy Suite

-5h 2m
Varian Medical Systems Inc.

Varian Unveils New Bravos Afterloader System for Brachytherapy Treatments

-5h 32m
G1 Therapeutics Inc.

G1 Therapeutics Presents Additional Data from Randomized Phase 2 Trial of Trilaciclib in Combination with Etoposide/Carboplatin for Treatment of First-Line Small Cell Lung Cancer

-6h 14m
Leap Therapeutics Inc.

Leap Therapeutics Presents Esophagogastric Cancer Data at ESMO 2018 Annual Congress

-8h 18m
Incyte Corporation

Summary ToggleIncyte Announces Positive Interim Data from Phase 2 Trial of Pemigatinib, Its Selective FGFR Inhibitor, in Patients with Cholangiocarcinoma

-8h 18m
Loxo Oncology Inc.

Loxo Oncology Announces Larotrectinib Clinical Update in Patients with TRK Fusion Cancers at the European Society for Medical Oncology 2018 Congress

-9h 9m
Mirati Therapeutics Inc.

Mirati Therapeutics Announces Updated Data From Ongoing Clinical Trial Of Single Agent Sitravatinib At The 2018 ESMO Congress

-9h 51m
The United States Navy

Histopathology on USNS Comfort

-16h 18m
Varian Medical Systems Inc.

Varian Forms FlashForward Consortium to Study Ultra-high Dose Rate Cancer Treatments with Protons

-19h 55m